Laboratory Investigation
United States and Canadian Academy of Pathology The United States and Canadian Academy of Pathology
LWW Lippincott Williams and Wilkins
publishes Laboratory Investigation
--
                                      View Future Titles
Through Mar 2001
       Archives
Aug 1965 - Feb 2001
       Search Articles
Aug 1965 - Feb 2001
       Browse by Subject
Aug 1965 - Feb 2001
                      
Instructions to authors

Subscriptions

About the journal
   
  Production of Macrophage Inflammatory Protein-1 alpha by Human Mast Cells: Increased Anti-IgE-Dependent Secretion after IgE-Dependent Enhancement of Mast Cell IgE-Binding Ability
Editorial board

Email alerts

'Net Tips

Help

Feedback

Guestbook








  Tetsuya Matsumoto, Kiyonobu Ikeda, Naofumi Mukaida, Akihisa Harada, Yoshihiro Matsumoto, Junkoh Yamashita, and Kouji Matsushima 
   
  Departments of Pathology (KY, MY, FM, CSL, JJC, SJG) and Medicine (JJC), Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts; and Division of Allergic Diseases (JHB), Department of Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 
   
  The contributions of mast cells to the pathology of allergic diseases, as well as to the expression of immunoglobulin E (IgE)-dependent host responses to parasites, reflect both the amounts and types of cytokines and other mediators that are released by these cells in such settings. Whereas mast cells cannot intrinsically express immunologically specific functions, the binding of IgE to high-affinity IgE receptors (Fc epsilon RI) on the surface of mast cells primes these cells to secrete cytokines and other biologically active products upon subsequent exposure to specific antigens. We now report that both HMC-1, a growth factor-independent human mast cell leukemia cell line, and growth factor-dependent human umbilical cord blood-derived mast cells can secrete the multifunctional C-C chemokine, macrophage inflammatory protein-1 alpha (MIP-1 alpha). In addition, we found that in vitro exposure of human umbilical cord blood-derived mast cells to concentrations of IgE within the range observed in the serum of subjects with allergic diseases or parasite infections, which markedly up-regulates the ability of these cells to bind IgE to their surface, also significantly enhances the ability of the cells to secrete MIP-1 alpha upon subsequent passive sensitization with IgE and challenge with anti-IgE. Thus, IgE-dependent enhancement of human mast cell IgE-binding ability permits these cells to respond to Fc epsilon RI-dependent challenge with significantly increased secretion of MIP-1 alpha, a chemokine that can have diverse functions in inflammation, allergic reactions, and host responses to infection.